E-mail this page Printer Friendly Version RSS E-mail Alerts View contacts Download Financial Tear Sheet 

Investor Relations

DGX (Common Stock)
ExchangeNYSE (US Dollar)
Change (%) Stock is Up 0.97 (1.09%)
Intraday High$89.96
Intraday Low$88.89
Data as of 12/08/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Webcast ImageWebcast - Replay
Quest Diagnostics Investor Day
11/11/16 at 8:00 a.m. ET
Webcast ImageWebcast - Replay
Q3 2016 Quest Diagnostics Earnings Conference Call
10/20/16 at 8:30 a.m. ET
Q3 2016 Quest Diagnostics Earnings Conference Call
Thursday, October 20, 2016 8:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Supporting Materials
Download Event Supporting Material Q3 2016 Presentation
Earnings Information
Q3 2016 Presentation
Headlines More >
Data Diagnostics Named Most Innovative Healthcare Product of the Year by 2016 Best in Biz Awards
Point-of-care healthcare analytics technology from Quest Diagnostics and Inovalon facilitates better care quality and value-based financial performance MADISON, N.J., Dec. 7, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX) and Inovalon (NASDAQ: INOV) today announced that Data Diagnostics™, a point-of-care healthcare analytics technology, has been named the Most Innovative Product of the Year for Healthcare in the Best in Biz Award annual competition, the only independent business awards ... 
Quest Diagnostics to Expand Consumer Offering Through Patient-Initiated Testing Services in Colorado and Missouri
Service provides patients autonomy over their own health by allowing them to choose from diagnostic tests without a physician's order MADISON, N.J., Nov. 21, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, has launched QuestDirect, a new Patient-Initiated Testing service which will empower consumers who live in Colorado and Missouri to manage their health by ordering certain lab tests directly without a physician's order. ... 
Quest Diagnostics Raises Revenue Growth Outlook, Increases Dividend at 2016 Investor Day
- Revenue growth beyond 2016 to be between 3-5%, earnings to grow faster than revenues in mid-to-high single digit range - Raises dividend by 12.5% to annual rate of $1.80 per share - Reaffirms Invigorate target of $1.3 billion run rate cost savings by end of 2017 - Quest to expand retail presence in Safeway stores to more than 50 by end of 2016, 200 by end of 2017 MADISON, N.J., Nov. 11, 2016 /PRNewswire/ -- At a meeting with analysts and investors at its Investor Day today, membe... 
Quest Diagnostics Reports Third Quarter 2016 Financial Results
- Revenues of $1.89 billion, up 0.3% on a reported basis and up 2.1% on an equivalent basis versus 2015 - Reported diluted EPS of $1.34, down 43.0% from 2015 due to the gain on contribution to Q2 Solutions last year - Adjusted diluted EPS excluding amortization of $1.37, up 7% from 2015 - Cash provided by operations of $301 million, up 41.7% from 2015 - Full year EPS outlook narrowed MADISON, N.J., Oct. 20, 2016 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the wor... 
Upcoming EventsMore >
There are currently no events scheduled.
Contact Us:
Shawn Bevec
Executive Director Investor Relations

Company Calendar
December 2016?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
52 Week High

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.